Table 2. Bacterial strains used in this study.
Strain | Relevant characteristics | Reference or source |
---|---|---|
SK36 | S. sanguinis wild-type | [48] |
DL1 | S. gordonii wild-type | [49] |
S. parasanguinis | ||
FW213 | S. parasanguinis wild-type | [48] |
FW213 bapA1 | bapA1 mutant | [19] |
FW213 fap1 | fap1 mutant | [50] |
FW213 bapA1-fap1 | bapA1-fap1 double mutant | [19] |
FW213 srtA | Sortase A mutant | [17] |
FW213 srtB | Sortase B mutant | [17] |
FW213 abpA | abpA mutant | [17] |
P. aeruginosa | ||
FRD1 | CF isolate, mucoid | [51] |
FRD1 mucA+ | Complemented with mucA, non-mucoid | [38] |
FRD1 algD | algD mutation, non-mucoid | [52] |
FRD1 algT | algT mutation, non-mucoid | [52] |
PAO1 | Wound isolate, non-mucoid | [53] |
PAO1 mucA | Deletion of mucA (PDO300) | [54] |
CF clinical isolates | C1-C3 mucoid, C4-C6 non-mucoid | UAB CF Center |